(Q58327426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Daniel Berney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

S S Jeetle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

G Fisher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Z H Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

E Stankiewicz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C S Cooper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

J Cuzick

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Trans-Atlantic Prostate Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

6 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

103-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00428-012-1259-2

7 February 2020

exact match

0 references

cites work

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

20-year outcomes following conservative management of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Long-term outcome among men with conservatively treated localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Clinical implications of neuroendocrine differentiation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Neuroendocrine differentiation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Neuro-endocrine cells--a new prognostic parameter in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1259-2

Do neuroendocrine cells in human prostate cancer express androgen receptor?

21 January 2018

1 reference

12 December 2020

Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.

1 reference

12 December 2020

Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancer

1 reference

12 December 2020

The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine Therapy

1 reference

12 December 2020

Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression

1 reference

12 December 2020

Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

1 reference

12 December 2020

Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan

1 reference

12 December 2020

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

1 reference

12 December 2020

Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer

1 reference

12 December 2020

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.

1 reference

12 December 2020

Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence

1 reference

12 December 2020

Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation

1 reference

12 December 2020

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

1 reference

12 December 2020

MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells

1 reference

12 December 2020

Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma

1 reference

12 December 2020

Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression

1 reference

12 December 2020

Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment

1 reference

12 December 2020

Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study

1 reference

12 December 2020

Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin

1 reference

12 December 2020

Prostate cancer and neuroendocrine differentiation

1 reference

12 December 2020

Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments

1 reference

12 December 2020

10.1007/S00428-012-1259-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22767265%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference